Avascular Necrosis Market, by Drug Type (Non-steroidal anti-inflammatory drugs (Ibuprofen, and Naproxen Sodium), Osteoporosis drugs, Cholesterol-lowering drugs, Blood Thinners, and Others), by Route of Administration (Oral, Injectable), by Distribution Ch
Description
Avascular Necrosis Market, by Drug Type (Non-steroidal anti-inflammatory drugs (Ibuprofen, and Naproxen Sodium), Osteoporosis drugs, Cholesterol-lowering drugs, Blood Thinners, and Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. This condition may happen in any bone of the body, but mostly happens in the ends of a long bone. A broken bone or dislocated joint can interrupt the blood flow to a section of bone. Avascular necrosis condition is most common in people between the ages of 30 and 50.
Avascular necrosis can be caused due to-
Injury to bone
Fracture
Damage of blood vessels
Long-term use of medicines, such as corticosteroids
Excessive, long-term use of alcohol
Avascular necrosis can be diagnosed by Bone scan, Magnetic Resonance Image and Computed Tomography, and X-rays. Medications used to treat avascular necrosis are blood thinners, nonsteroidal anti-inflammatory drugs, cholesterol lowering drugs and others.
Market Dynamics
Increasing number of product launches is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in September 2014, Bayer Healthcare LLC, a pharmaceutical and medicine manufacturing company, announced the launch of Aleve PM, an over-the-counter (OTC) pain reliever product in the U.S.
Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global avascular necrosis market. For instance, in April 2019, the U.S Food and Drugs Administration approved Evenity (romosozumab-aqqg), a sclerostin inhibitor indicated to treat osteoporosis in postmenopausal women at high risk of breaking a bone.
Key features of the study:
This report provides an in-depth analysis of the global avascular necrosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited., Bayer AG, Rochem International, Inc., Alkem Labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global avascular necrosis market
Detailed Segmentation:
Global Avascular Necrosis Market, By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol- lowering drugs
Blood Thinners
Others
Global Avascular Necrosis Market, By Route of Administration:
Oral
Injectable
Global Avascular Necrosis Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Avascular Necrosis Market, By Region:
North America
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Teva Pharmaceuticals Industries Ltd. *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Dr. Reddy’s Laboratories Ltd.
Solara Active Pharma Sciences Limited.
Bayer AG
Rochem International, Inc.
Alkem Labs
Dwarkesh Pharmaceuticals Private Limited
Novartis AG
GSK
Pfizer, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. This condition may happen in any bone of the body, but mostly happens in the ends of a long bone. A broken bone or dislocated joint can interrupt the blood flow to a section of bone. Avascular necrosis condition is most common in people between the ages of 30 and 50.
Avascular necrosis can be caused due to-
Injury to bone
Fracture
Damage of blood vessels
Long-term use of medicines, such as corticosteroids
Excessive, long-term use of alcohol
Avascular necrosis can be diagnosed by Bone scan, Magnetic Resonance Image and Computed Tomography, and X-rays. Medications used to treat avascular necrosis are blood thinners, nonsteroidal anti-inflammatory drugs, cholesterol lowering drugs and others.
Market Dynamics
Increasing number of product launches is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in September 2014, Bayer Healthcare LLC, a pharmaceutical and medicine manufacturing company, announced the launch of Aleve PM, an over-the-counter (OTC) pain reliever product in the U.S.
Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global avascular necrosis market. For instance, in April 2019, the U.S Food and Drugs Administration approved Evenity (romosozumab-aqqg), a sclerostin inhibitor indicated to treat osteoporosis in postmenopausal women at high risk of breaking a bone.
Key features of the study:
This report provides an in-depth analysis of the global avascular necrosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited., Bayer AG, Rochem International, Inc., Alkem Labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global avascular necrosis market
Detailed Segmentation:
Global Avascular Necrosis Market, By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol- lowering drugs
Blood Thinners
Others
Global Avascular Necrosis Market, By Route of Administration:
Oral
Injectable
Global Avascular Necrosis Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Avascular Necrosis Market, By Region:
North America
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Ibuprofen
Naproxen Sodium
Osteoporosis drugs
Cholesterol-lowering drugs
Blood Thinners
Others
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Teva Pharmaceuticals Industries Ltd. *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Dr. Reddy’s Laboratories Ltd.
Solara Active Pharma Sciences Limited.
Bayer AG
Rochem International, Inc.
Alkem Labs
Dwarkesh Pharmaceuticals Private Limited
Novartis AG
GSK
Pfizer, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
147 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Route of Administration
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Product Launches/Approvals
- Regulatory Scenario
- Epidemiology
- PEST Analysis
- Acquisition and Collaboration Scenario
- 4. Impact of COVID-19 on the Global Avascular Necrosis Market
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Avascular Necrosis.
- Government Initiative
- 5. Global Avascular Necrosis Market, By Drug Type, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Nonsteroidal anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Ibuprofen
- Naproxen Sodium
- Osteoporosis drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cholesterol-lowering drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Blood Thinners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Avascular Necrosis Market, By Route of Administration, 2017 - 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Ibuprofen
- Naproxen Sodium
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 7. Global Avascular Necrosis Market, By Distribution Channel, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 8. Global Avascular Necrosis Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Company Profiles
- Teva Pharmaceuticals Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dr. Reddy’s Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Solara Active Pharma Sciences Limited.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Rochem International, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alkem Labs.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dwarkesh Pharmaceuticals Private Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GSK
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 42 market data tables and 40 figures on "Avascular Necrosis Market” – Global Forecast to 2028”
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
